SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Repligen Corp (RGEN) -- Ignore unavailable to you. Want to Upgrade?


To: Thomas M. who wrote (76)5/6/1998 10:12:00 AM
From: mark alan rosenberg  Read Replies (1) | Respond to of 395
 
Other co.s in this field are starting to get mentioned. RGEN
is in a phase 2 trial. Is it for angionesis inhibition, and are
they using humans? I know they are using a small molecule approach.